Tocriscreen Library of FDA-Approved Compounds

Name	Tocriscreen Library of FDA-Approved Compounds
Supplier	Tocris Bioscience
Catalog	5268
Prices	$3,995.00
Sizes	1 set
Description	A library of 160 FDA-approved compounds. Comprises a subset of the Tocriscreen Plus (Cat. No. 5840) compound library. Contains compounds covering a range of therapeutic classes e.g. the cardiovascular and nervous systems and research areas such as cancer and immunology. Includes both established gold-standard compounds, e.g. tamoxifen, paclitaxel, as well as more recent highly selective, targeted compounds, such as gefitinib and axitinib.
Supplier Page	Shop

Product References

A coiled-coil enabled split-luciferase three-hybrid system: applied toward - A coiled-coil enabled split-luciferase three-hybrid system: applied toward

Jester BW, Cox KJ, Gaj A, Shomin CD, Porter JR, Ghosh I. J Am Chem Soc. 2010 Aug 25;132(33):11727-35.

Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen - Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen

Moujalled D, James JL, Parker SJ, Lidgerwood GE, Duncan C, Meyerowitz J, Nonaka T, Hasegawa M, Kanninen KM, Grubman A, Liddell JR, Crouch PJ, White AR. PLoS One. 2013 Jun 26;8(6):e67433. Print 2013.